Is it feasible to use granulocyte-colony stimulating factor alone to mobilize progenitor cells in multiple myeloma patients induced with a cyclophosphamide, thalidomide and dexamethasone regimen?

BACKGROUND: Cyclophosphamide plus thalidomide as induction for multiple myeloma patients eligible for autologous stem cell transplantation may be a limiting factor for cell mobilization. The minimum acceptable mobilized peripheral blood stem cell count to prevent deleterious effects during transplan...

Descripción completa

Detalles Bibliográficos
Autores principales: Crusoe, Edvan de Queiroz, Higashi, Fabiana, Martinez, Gracia Aparecida, Barros, José Carlos, Bellesso, Marcelo, Rossato, Marina, Marret, Ana Cinira F., Chiattone, Carlos Sérgio, Hungria, Vania Tietsch de Moraes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119677/
https://www.ncbi.nlm.nih.gov/pubmed/27863757
http://dx.doi.org/10.1016/j.bjhh.2016.06.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119677/
https://www.ncbi.nlm.nih.gov/pubmed/27863757
http://dx.doi.org/10.1016/j.bjhh.2016.06.004

Ejemplares similares